STI Intensive

STI Intensive

January 30, 2025
Event registration and details including agenda, final start and end times and number of CME units available will be announced on or before December 9th. 

Please join us for a morning half-day STI Intensive offered in-person and virtually at no cost at the University of California, San Francisco at the ZSFG campus. There will also be an in-person (only) afternoon wet-mount at the UCSF Parnassus campus available to a limited number of the morning-training participants at no cost. This event will begin with a local epidemiology presentation followed by presentations from CAPTC speakers including Drs. Ina Park, Kelly Johnson, Rosalyn Plotzker, Sharon Adler, and Wyatt Hanft.

½ Day Didactic: Morning – Early Afternoon

  • Hybrid event being offered in-person at UCSF Pride Hall & Virtually by Zoom
  • Onsite breakfast and refreshments provided
  • CME will be offered at no cost
  • Topics will cover STI trends (national and California); biomedical STI prevention; syphilis cases; updates in STI management, with a focus on syphilis, mycoplasma genitalium and HPV.
  • Registration closes on January 29, 2025 at 3:00p.m. (PST)
  • Recording available in approximately 2 weeks after the event. Please note: CME not available for viewing the recording.

Wet Mount: Mid Afternoon-Evening

Previous microscopy skills are required to take this course. Registration prioritized for STI Intensive didactic attendees. Space limited to 12 max capacity.

  • In-person only training being offered at UCSF Parnassus Heights
  • 3-hour laboratory course
  • CME will be offered at no cost
  • Topics will cover CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. Microscope footage of findings on VWM including trichomonads, yeast and clue cells associated with BV. Experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). Participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
  • Registration closes on January 29, 2025 at 3:00p.m. (PST) or once course is full.

STI Clinical Update Webinar – Syphilis in Pregnancy

November 20, 2024
12:00PM-1:15PM (PST)
1.25 CME units at no cost

Presenters

Kathleen Jacobson, MD
Chief, STD Control Branch, California Department of Public Health

Wyatt Hanft, MD, MPH
STI Fellow, STD Control Branch, California Department of Public Health & California Prevention Training Center at UCSF

Course Description

Drs. Kathleen Jacobson and Wyatt Hanft will provide a 1-hour virtual training focused on syphilis clinical presentation, screening/testing, diagnosis, treatment, and follow-up for pregnant patients. The presenters will use a case-based format to help attendees apply the learned material to a real-life scenario.

Learning Objectives

  • Review the epidemiology of syphilis and congenital syphilis (CS) in California
  • Apply the American College of Obstetrics and Gynecology (ACOG) screening recommendations during pregnancy
  • Compare traditional and reverse screening algorithms for syphilis
  • Describe syphilis diagnosis, treatment and follow up during pregnancy

Calculating Interview Periods

A foundational step in any STI interview is determining the interview period. This timeframe is crucial for identifying sexual partners who may require testing and treatment. The DI Professional will calculate this period before the interview begins. The interview period represents the maximum possible duration during which the person could have contracted or transmitted the infection.

Module Objective:

To equip DI Professionals with the knowledge and skills necessary to accurately calculate interview periods for persons diagnosed with STIs/HIV.

In this e-learning module learners will:

  • Define interview period and its importance in working with people who are diagnosed with an STI/HIV.
  • Discuss factors affecting interview period length (e.g., STI type, symptoms, risk behaviors).
  • Calculate Interview Periods for Specific STIs using different patient profiles and STI/HIV diagnoses(Primary, Secondary, and Early Latent syphilis, Chlamydia, Gonorrhea, PID, and HIV).

STI Clinical Update-Sacramento and Yolo Counties: Congenital Symposium

In-person only event

Monday, October 28, 2024
9:00AM-3:30PM (PDT)
Sacramento, CA
5.00 CME units at no cost

Please note: This is an in-person only event onsite in Sacramento, CA. Registration is limited to local DIS and clinicians in the Sacramento and Yolo counties region. Registration closes on October 25th at 3:00PM (PDT).

Questions: Please email Clinical Program Manager, Elizabeth Olson, elizabeth.olson@ucsf.edu.

Learning Objectives:

Participants will be able to:

  • Recognize common manifestations of primary and secondary syphilis, compare traditional and reverse screening algorithms, and determine appropriate syphilis staging, treatment, and follow-up.
  • Implement CDC recommendations for CS testing and treatment based on infant and birthing parent labs and exam at the time of delivery, and apply current CDPH syphilis screening guidelines to pregnant people in California.
  • Cite evidence supporting doxy-PEP use, understand CDPH recommendations for doxy-PEP prescribing, and counsel patients on potential risks/benefits and follow-up for this biomedical prevention method.
  • Cite local trend data illustrating increased rates of Congenital Syphilis and syphilis among women, as a rationale for enhanced clinical screening for STIs for people who may become pregnant and during pregnancy.
  • Identify at least two local approaches to congenital syphilis prevention, including how to obtain wrap-around services for pregnant people with syphilis, and resources provided via partnerships with local surveillance programs.

Presenters
Dr. Wyatt Hanft
STI Fellow, California Prevention Training Center & California Department of Public Health, STD Control Branch

Dr. Kurtis Mohr
Public Health Medical Officer, California Department of Public Health, STD Control Branch

Dr. Wyatt Hanft and Dr. Kurtis Mohr

Prenatal Syphilis Screening, Staging, and Management for Congenital Syphilis Prevention

Prenatal Syphilis Screening, Staging, and Management for Congenital Syphilis Prevention

This pocket guide summarizes all the essentials of prenatal syphilis screening, staging, and management with the goal of preventing congenital syphilis. 

various microscopic images of pathogens

July 2024 PrEP Learning Collaborative Injectable PrEP Update

July 2024 PrEP Learning Collaborative Injectable PrEP Update

Thursday, July 18, 12-1pm PDT

Slides

Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation). 

Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.

PrEP Learning Collaborative Injectable PrEP Update 7/18/24

Slides

Special Guest: Stefan Madzar, PrEP & HIV Benefits Coordinator & Linkage Navigator at Magnet (San Francisco AIDS Foundation). 

Stefan will present an update on Magnet’s injectable PrEP program, including challenges, successes, and lessons learned, and featuring clients who will discuss their experiences taking injectable PrEP.

Thursday, July 18, 12-1pm PDT

STI Clinical Update Webinar– Summer 2024 Update and Review: Syphilis, Chlamydia, and Gonorrhea, County of Lake

Presented by Drs. Kelly Johnson and Kurtis Mohr
Wednesday, July 24, 2024
11:00AM – 1:00PM (PDT)

CME not available for viewing the webinar recording.

""

Learning Objectives

  • Describe the varied clinical manifestations of primary and secondary syphilis in adults and adolescents
  • Appropriately stage and treat syphilis in both pregnant and non-pregnant people
  • Recognize the different sequelae of sexually transmitted C. trachomatis and N. Gonorrhoeae infections & their recommended treatments

Mpox Job Aids

CAPTC is pleased to announce two job aids, focused on mpox recognition, diagnosis, testing, treatment, and vaccination.

The shorter job aid is called “Mpox Clinical Recognition and Testing Quicksheet: Mpox Presentations vs. Common Exanthems.” It is intended as a print resource, to help facilitate clinical recognition of mpox in health care settings. The longer job aid, “Mpox Clinical Recognition and Testing Overview,” is intended as an electronic resource. It has links to a number of helpful mpox-related resources.

You can find the sources of images used in the quicksheet here:

Mpox Disease Intervention Series

The goal of this training is to prepare staff of local health departments to perform effective disease intervention (DI) interviews for mpox. This training aims to build on disease intervention skills by applying knowledge of the complexities and nuances specifically related to mpox DI interviews.

Learning Objectives
By the end of these trainings, you should be able to:

  1. Communicate accurate information about mpox symptoms, transmission, prevention, treatment, and services.
  2. Gain awareness of the lived experiences of gay, bi, other men who have sex with men (MSM), including transgender men, and other trans people as it relates to mpox.
  3. Understand a sex-positive, person-centered approach to taking a sexual history for mpox.
  4. Use motivational interviewing and health coaching tools to support clients in seeking vaccination, screening, or treatment for mpox.
  5. Examine personal and structural biases to reduce stigma during mpox interviews.